Stone Four Pharmaceutical Group: Mesobamol Tablets Obtains Drug Production Registration Approval.

ShiSi Pharmaceutical Group announced that it is the first domestic enterprise in China to obtain the drug production registration certificate for Meprobamate tablets from the China National Medical Products Administration. This drug belongs to the third category of chemical drugs and is considered to have passed consistency evaluation. Meprobamate is a muscle relaxant used primarily for conditions such as joint muscle sprains, lumbar muscle strain, and sciatica.